- Home
- IOVA vs EQX Comparison
IOVA vs EQX Comparison
Compare IOVA & EQX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- EQX
- Stock Information
- Founded
- IOVA 2007
- EQX 2007
- Country
- IOVA United States
- EQX Canada
- Employees
- IOVA N/A
- EQX N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- EQX Precious Metals
- Sector
- IOVA Health Care
- EQX Basic Materials
- Exchange
- IOVA Nasdaq
- EQX Nasdaq
- Market Cap
- IOVA 2.6B
- EQX 2.7B
- IPO Year
- IOVA N/A
- EQX N/A
- Fundamental
- Price
- IOVA $7.73
- EQX $5.38
- Analyst Decision
- IOVA Strong Buy
- EQX
- Analyst Count
- IOVA 9
- EQX 0
- Target Price
- IOVA $23.33
- EQX N/A
- AVG Volume (30 Days)
- IOVA 5.4M
- EQX 4.2M
- Earning Date
- IOVA 11-07-2024
- EQX 11-06-2024
- Dividend Yield
- IOVA N/A
- EQX N/A
- EPS Growth
- IOVA N/A
- EQX 302.88
- EPS
- IOVA N/A
- EQX 0.60
- Revenue
- IOVA $90,858,000.00
- EQX $1,236,929,000.00
- Revenue This Year
- IOVA $13,758.71
- EQX $46.67
- Revenue Next Year
- IOVA $171.64
- EQX $55.51
- P/E Ratio
- IOVA N/A
- EQX $8.98
- Revenue Growth
- IOVA 12751.20
- EQX 17.84
- 52 Week Low
- IOVA $6.70
- EQX $3.95
- 52 Week High
- IOVA $18.33
- EQX $6.50
- Technical
- Relative Strength Index (RSI)
- IOVA 34.99
- EQX 44.07
- Support Level
- IOVA $7.69
- EQX $5.28
- Resistance Level
- IOVA $8.14
- EQX $6.48
- Average True Range (ATR)
- IOVA 0.38
- EQX 0.25
- MACD
- IOVA -0.07
- EQX -0.05
- Stochastic Oscillator
- IOVA 8.77
- EQX 8.37
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About EQX Equinox Gold Corp.
Equinox Gold Corp is a mining company engaged in the operation, acquisition, exploration and development of mineral properties, with a focus on gold. Equinox Gold has around seven operating gold mines and a clear plan to increase production by advancing pipeline of growth projects.